Per Svenningsson's research group
Translational Research on Neuropharmacology and Movement Disorders.
Parkinson's disease (PD) is a common disease where the basic pathophysiology is unclear. The next breakthrough in the treatment of PD should delay disease progression, based on insights into the underlying pathogenic process. The development of disease-modifying drugs is hampered by the lack of adequate diagnostics and biomarkers that reflect early signs of the disease.
News and announcements
Outreach (in the media)
We’ve had the oportunity to promote public awareness and education about movement disorders and our research in some occasions. Here are some examples
Our research has been supported by grants from several different institutions and funding agencies.